Australia markets closed

Alpine Immune Sciences, Inc. (ALPN)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
64.56-0.06 (-0.09%)
At close: 04:00PM EDT
64.60 +0.04 (+0.06%)
After hours: 07:12PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 4.23B
Enterprise value 3.92B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)54.83
Price/book (mrq)12.91
Enterprise value/revenue 66.50
Enterprise value/EBITDA -124.66

Trading information

Stock price history

Beta (5Y monthly) 1.16
52-week change 3761.95%
S&P500 52-week change 322.36%
52-week high 364.70
52-week low 36.71
50-day moving average 343.37
200-day moving average 322.32

Share statistics

Avg vol (3-month) 32.21M
Avg vol (10-day) 32.48M
Shares outstanding 565.56M
Implied shares outstanding 665.56M
Float 844.94M
% held by insiders 14.65%
% held by institutions 191.48%
Shares short (15 Apr 2024) 44.74M
Short ratio (15 Apr 2024) 41.25
Short % of float (15 Apr 2024) 411.79%
Short % of shares outstanding (15 Apr 2024) 47.23%
Shares short (prior month 15 Mar 2024) 45.61M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 325 July 2017
Ex-dividend date 4N/A
Last split factor 21:4
Last split date 325 July 2017

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -54.66%
Operating margin (ttm)5.01%

Management effectiveness

Return on assets (ttm)-8.30%
Return on equity (ttm)-12.69%

Income statement

Revenue (ttm)58.88M
Revenue per share (ttm)1.18
Quarterly revenue growth (yoy)1,011.40%
Gross profit (ttm)N/A
EBITDA -43.67M
Net income avi to common (ttm)-32.18M
Diluted EPS (ttm)-0.64
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)327.41M
Total cash per share (mrq)4.99
Total debt (mrq)9.91M
Total debt/equity (mrq)3.02%
Current ratio (mrq)7.86
Book value per share (mrq)5.43

Cash flow statement

Operating cash flow (ttm)-79.01M
Levered free cash flow (ttm)-29.06M